Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
AstraZeneca pharmaceutical invests $200 million for Frederick, Maryland biologics manufacturing center expansion
Introduction AstraZeneca announced plans to expand its biologics manufacturing center in Frederick, Maryland with an investment of more than $200 million The expansion of this project is expected to complete in mid2017 Features AstraZenecas Frederick biologic
Japan-based Takeda Pharmaceutical invests $25m in drug discovery firm BioMotiv
Introduction BioMotiv and Takeda Pharmaceutical Company has entered into Strategic Partnership,where Takeda has made a initial investment of $25million in BioMotiv Features This partnership will leverage the strengths of both organizations to identify and develop pionee
Xellia Pharma Invests US$100m and Promises 40 new jobs in Raleigh Facility
Denmarkbased Xellia Pharmaceuticals has announced its plans to invest US$100 million in the expansion of its manufacturing plant located at 8900 Capital Boulevard in the City of Raleigh Retaining 90 existing jobs, the company also plans to create 40 permanent fulltime jobs over next five years with average annual salaries to range from US$45,000 t...
Pfizer Continues Investment in Irish Plants
USbased Pfizer is investing US$130 million into Irish plants, as part of its ongoing expansion plans Pfizer invests US$100m into Grange Castle, west Dublin biologics unit and US$30m into Ringaskiddy plant in County Cork The Department of Jobs, Enterprise and Innovation through IDA Ireland, willsupport the investmentsand will support the sites to e...
German Merck Plans US$107.67 million Plant in China
Merck KGaA plans to construct a new plant in China to manufacture diabetes drugs and address critical healthcare needs of the Chinese population Location The new plant is planned to be built in Shaghai, China covering an area of 40,000 square meters The plant will have a room for a 20,000squaremeter expansion
KBR Arm to Build Oral Solid Dosage Plant for Prudue Pharma
Prudue Pharma Manufacturing LP has entered into an agreement with KBR Ltds KBR Services Group subsidiary for the construction of a 150,000squarefoot steelframed Oral Solid Dosage manufacturing plant in Treyburn Corporate Park, Durham The new facilitys construction began this year and is expected to be completed by 2015 Budget
UPM Pharmaceuticals Expands Bristol Plant
UPM Pharmaceuticals has announced that as a part of a multitier plan to update the facility, it is currently planning to expand its Bristol plant Background This 475,000square foot commercial manufacturing facility was acquired from Pfizer to provide largescale commercial capabilities for manufacturing and packaging of solid
GVK Biosciences Plans New API Facility in Visakhapatnam
Introduction GVK Biosciences plans to set up a second Active Pharmaceutical Ingredients APIs manufacturing facility in Visakhapatnam It has an existing plant in Hyderabad with a capacity of 135 kilolitres Features The new facility would have a production capacity o
WuXi PharmaTech’s New R&D and cGMP Manufacturing Campus in Changzhou
Introduction SynTheAll STA Pharmaceuticals Co, Ltd, a manufacturing subsidiary of WuXi PharmaTech has begun construction of a new and fully integrated RD and cGMP manufacturing site in Changzhou, 110 miles west of Shanghai, China This construction is aimed at fulfilling the rapidly increasing demands of WuXis manufacturing services
AbbVie’s First Manufacturing Facility in Singapore (US$ 320 million)
Introduction AbbVie is all set to install its first manufacturing facility in Asia which will be operational from 2019 Located in Singapore, this facility will support an emerging antibodydrug conjugate ADC pipeline This would be the first facility of AbbVie since it had split out of Abbott Laboratories in 2012 and made its own identity
